Results 201 to 210 of about 237,523 (354)
Eosinophils in solid cancers: sentinels, predictors, and therapeutic allies. [PDF]
Gilon M +5 more
europepmc +1 more source
Multi‐Omic Profiling Reveals Immune Cell Priming Signature Linked to Lupus Prognosis
Objective Systemic lupus erythematosus (SLE) is a multiorgan disease with widespread immune dysregulation and significant unmet clinical need. Blood‐based gene expression studies have advanced our understanding of SLE pathogenesis but may overlook critical tissue‐specific mechanisms that drive disease heterogeneity and progression.
Michael A. Smith +23 more
wiley +1 more source
Increased alveolar tissue destruction in a sub-group of COPD patients with increased alveolar septal eosinophil counts. [PDF]
Higham A +4 more
europepmc +1 more source
Objective To assess the 2022‐ACR/EULAR classification criteria for ANCA‐associated vasculitis (AAV) in children with chronic small‐to‐medium vessel vasculitis. Methods A cohort of 574 patients, identified by physician's‐(MD)‐diagnosis in A‐Registry‐of‐Childhood‐Vasculitis, were classified by computation of registry data, as having granulomatosis with ...
David A. Cabral +41 more
wiley +1 more source
Blood eosinophil count as a biomarker for therapy guidance in COPD and asthma exacerbations. [PDF]
Godallage AN +5 more
europepmc +1 more source
Eosinophil depletion suppresses radiation-induced small intestinal fibrosis
Naoki Takemura +24 more
semanticscholar +1 more source
Objectives The hematopoietic system maintains homeostasis by balancing myeloid and lymphoid cell production in the bone marrow (BM). In response to increased hematopoietic demand, extramedullary hematopoiesis (EMH) may occur in non‐lymphoid organs. We investigated the role of EMH and kidney‐resident hematopoietic stem and progenitor cells (HSPCs) in ...
Hansol Yi +9 more
wiley +1 more source
AASLD practice guidance on drug, herbal, and dietary supplement–induced liver injury
Hepatology, EarlyView.
Robert J. Fontana +6 more
wiley +1 more source
Beyond Triple Therapy: Anti-Type 2 Biologic Therapies for Eosinophilic COPD and Respiratory Comorbidities - a Review of Clinical Evidence. [PDF]
Mari PV +15 more
europepmc +1 more source

